Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS

NCT02921061 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Mixed Phenotype Acute Leukemia
Previously Treated Myelodysplastic Syndrome
Recurrent Adult Acute Myeloid Leukemia
Recurrent High Risk Myelodysplastic Syndrome
Refractory Acute Myeloid Leukemia
Refractory High Risk Myelodysplastic Syndrome
Untreated Adult Acute Myeloid Leukemia

Interventions

DRUG: Cladribine
DRUG: Cytarabine
DRUG: Decitabine
BIOLOGICAL: Filgrastim
OTHER: Laboratory Biomarker Analysis
DRUG: Mitoxantrone Hydrochloride

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]